Clinical Trial Update: The Effect of Probiotics on Non Alcoholic Fatty Liver Disease [Phase 1]

View source ↗

Summary

The Rabin Medical Center-sponsored Phase 1 trial investigating probiotics for non-alcoholic fatty liver disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Probiotics

Snippet

Sponsor: Rabin Medical Center | Conditions: Liver Disease | Phase 1 | Status: TERMINATED